NCT04077853View on ClinicalTrials.gov

Progesterone in Expectantly Managed Early-onset Preeclampsia

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 15, 2019

Primary Completion Date

October 30, 2021

Study Completion Date

January 15, 2022

Conditions
Preeclampsia
Interventions
DRUG

17 Hydroxyprogesterone Capronate

Intramuscular injection 250 mg

Trial Locations (1)

002

Ahmed Abbas, Assiut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04077853 - Progesterone in Expectantly Managed Early-onset Preeclampsia | Biotech Hunter | Biotech Hunter